DE69321123D1 - Entzündungshemmende Verbindungen zur ophthalmischer Verwendung - Google Patents

Entzündungshemmende Verbindungen zur ophthalmischer Verwendung

Info

Publication number
DE69321123D1
DE69321123D1 DE69321123T DE69321123T DE69321123D1 DE 69321123 D1 DE69321123 D1 DE 69321123D1 DE 69321123 T DE69321123 T DE 69321123T DE 69321123 T DE69321123 T DE 69321123T DE 69321123 D1 DE69321123 D1 DE 69321123D1
Authority
DE
Germany
Prior art keywords
compounds
inflammatory compounds
ophthalmic use
inflammatory
inflammed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321123T
Other languages
English (en)
Other versions
DE69321123T2 (de
Inventor
John Boltralik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of DE69321123D1 publication Critical patent/DE69321123D1/de
Publication of DE69321123T2 publication Critical patent/DE69321123T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69321123T 1990-11-13 1993-05-17 Entzündungshemmende Verbindungen zur ophthalmischer Verwendung Expired - Fee Related DE69321123T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61359590A 1990-11-13 1990-11-13
CA002140345A CA2140345C (en) 1990-11-13 1993-05-17 Anti-inflammatory compounds for ophthalmic use
PCT/US1993/004671 WO1994026769A1 (en) 1990-11-13 1993-05-17 Anti-inflammatory compounds for ophthalmic use

Publications (2)

Publication Number Publication Date
DE69321123D1 true DE69321123D1 (de) 1998-10-22
DE69321123T2 DE69321123T2 (de) 1999-03-04

Family

ID=27169933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321123T Expired - Fee Related DE69321123T2 (de) 1990-11-13 1993-05-17 Entzündungshemmende Verbindungen zur ophthalmischer Verwendung

Country Status (9)

Country Link
EP (1) EP0650496B1 (de)
AT (1) ATE171187T1 (de)
AU (1) AU676481B2 (de)
CA (1) CA2140345C (de)
DE (1) DE69321123T2 (de)
DK (1) DK0650496T3 (de)
ES (1) ES2120503T3 (de)
HK (1) HK1013295A1 (de)
WO (1) WO1994026769A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181720A (en) * 1978-04-05 1980-01-01 Syntex (U.S.A.) Inc. Corticosteroid antiinflammatory agents
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
JPH02134396A (ja) * 1988-11-15 1990-05-23 Taisho Pharmaceut Co Ltd ２１−アルコキシプレグナン誘導体

Also Published As

Publication number Publication date
AU676481B2 (en) 1997-03-13
EP0650496A1 (de) 1995-05-03
WO1994026769A1 (en) 1994-11-24
CA2140345C (en) 2001-01-16
DK0650496T3 (da) 1999-06-14
HK1013295A1 (en) 1999-08-20
DE69321123T2 (de) 1999-03-04
CA2140345A1 (en) 1994-11-24
AU4379093A (en) 1994-12-12
EP0650496B1 (de) 1998-09-16
ES2120503T3 (es) 1998-11-01
ATE171187T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
EP1225168B8 (de) Prostaglandin-F-2-alpha Derivat zur Behandlung von Glaukom und Augenhochdruck
EP0105635A3 (en) Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therepeutic agents
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE69100364D1 (de) Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung.
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE418989T1 (de) Verwendung von sub-antimikrobiellen tetracyclinen zur behandlung von okularer rosacea
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
DE69423782D1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ATE171187T1 (de) Entzündungshemmende verbindungen zur ophthalmischer verwendung
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
CA2192965A1 (en) Anandamide analogue compositions and method of treating intraocular hypertension using same
SU648187A1 (ru) Состав дл консервировани роговиц человека
DE60129725D1 (de) Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss
ES8200886A1 (es) Procedimiento para la preparacion de derivados del amino-1 propanol-2
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
NO901987D0 (no) Prostaglandinderivater for behandling av glaukom eller okular hypertensjon.
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ES1009573U (es) Protesis externa y ajustable para el tratamiento traumatologico de extremidades inferiores.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee